Starpharma Holdings Limited
(ASX:SPL, OTCQX:SPHRY) today announced the signing of a research and collaboration
agreement between its wholly owned US subsidiary, DNT Inc, and a prominent,
US-based agricultural chemicals company. The confidentiality provisions of the
agreement prevent disclosure of the name of the collaborating company at this
time.
Under the agreement the parties will use DNT’s Priostar® dendrimer
technology to enhance the performance of existing pesticides. The approach is
a natural extension of Starpharma’s drug delivery work, in which dendrimers
extend the persistence of an active molecule, potentially reducing the amount
of active that is required for a given effect.
The agreement applies to specific classes of pesticides, and does not prevent
Starpharma’s further commercialisation of dendrimers more widely in the
agricultural chemicals sector.
The global market for agricultural chemicals for 2008 was estimated to be US$123.5
billion, of which pesticides represented US$35.8 billion.
“Agricultural applications offer an exciting and significant opportunity
for the Company in what is a completely new market for Starpharma’s proprietary
technology,” said Dr Jackie Fairley, CEO Starpharma.
“Starpharma is committed to building its revenues through partnering
with market leaders in selected, commercially attractive industry sectors, as
this deal and our previous partnerships illustrate. This strategy allows us
to rely on partners’ product knowledge and market position to rapidly
achieve diversification of our commercial base, whilst enabling the Company
to focus its own resources on its core competencies and lead products,”
Dr Fairley added.
Starpharma’s other areas of commercial exploitation of dendrimer technology
include: sexual health (VivaGel® coated condoms – licensed to SSL
International, and VivaGel® topical microbicide); drug delivery with GSK’s
Stiefel laboratories; in vitro diagnostics through Siemens Healthcare; laboratory
reagents through Qiagen and EMD Merck; and animal health through Eli Lilly’s
Elanco.